Corteva Raises Full-Year Outlook as It Prepares for October Split Into Two Companies
The agriscience firm posted 10% EBITDA growth in the first half and affirmed it remains on track to separate its seed and crop protection businesses by Oct. 1.
Strong First-Half Performance Drives Guidance Raise
Corteva, Inc. raised its full-year earnings outlook following a strong first half that saw operating EBITDA increase 10% and operating earnings per share climb 14%, even as the agricultural inputs company prepares to split into two entities on Oct. 1 (earnings call, 2026-07-31).
The company now expects operating EBITDA of $4.1 billion to $4.3 billion and operating EPS of $3.60 to $3.80 per share for 2026, representing approximately 9% EBITDA growth and 11% EPS growth at the midpoint versus 2025 (earnings call, 2026-07-31).
For the first half, net sales increased 4% to $11.3 billion, while operating EBITDA reached $3.7 billion. Margin expanded to 32.8%, driven by value capture in the seed business, productivity improvements across both segments, and disciplined cost management (earnings call, 2026-07-31).
"The headline for this quarter is straightforward: we are delivering strong results, we are raising our full year outlook and we are on track to complete our separation on October 1," CEO Chuck Magro said (earnings call, 2026-07-31).
Technology Adoption Offsets Pricing Pressure
The results reflected divergent dynamics across Corteva's two main business units. The seed business saw organic sales growth across all regions, with farmers continuing to prioritize technologies that improve productivity despite tight margins. The company's licensing business also contributed to growth (earnings call, 2026-07-31).
Crop protection faced ongoing pricing pressure, particularly in Latin America, due to competitive market dynamics. However, volume gains on new products—which are becoming a larger portion of the business—remained robust, with high single-digit growth in new product adoption (earnings call, 2026-07-31).
Cost performance was the largest contributor to EBITDA improvement, adding more than $160 million through lower input costs, manufacturing efficiencies, and productivity initiatives. Currency provided an approximately $85 million benefit during the first half, primarily from the euro (earnings call, 2026-07-31).
Separation on Track and Under Budget
Corteva confirmed it remains on track to complete its separation into two public companies—New Corteva for crop protection and Vylor for advanced seed and genetics—by Oct. 1. The company has largely offset dyssynergies on a run rate basis, with only about $25 million in headwinds expected this year due to separation timing (earnings call, 2026-07-31).
Key milestones achieved include the appointment of Luke Kissam as CEO of New Corteva, completion of leadership teams, public filing of the Form 10, and appointment of both boards of directors. According to MarginX data, Kissam recently received an award of 24,138 shares. An investor day is scheduled for Sept. 15 in New York.
"We have maintained our performance while simultaneously preparing to launch 2 public companies. That speaks to the strength of our organization and the commitment of our people," Magro said (earnings call, 2026-07-31).
This was Magro's final earnings call as CEO of the combined organization. Since Corteva's formation in 2019 through early 2026, the company improved operating EBITDA by $1.7 billion with over 750 basis points of margin enhancement, while investing nearly $9 billion in R&D and returning close to $8 billion to shareholders (earnings call, 2026-07-31).
MarginX data shows Corteva has a cash dividend of $0.18 scheduled for Sept. 1, with the company's market capitalization standing at approximately $53 billion.
This article was generated by MarginX from the earnings call on 2026-07-31. It is not investment advice.